Volume 21 Issue 9
Sep.  2023
Turn off MathJax
Article Contents
LI Yu, XIANG Ping, KONG Lingquan, HUANG Tao. Clinical diagnosis, treatment and analysis of 71 cases of chromophobe renal cell carcinoma in a single center[J]. Chinese Journal of General Practice, 2023, 21(9): 1453-1456. doi: 10.16766/j.cnki.issn.1674-4152.003144
Citation: LI Yu, XIANG Ping, KONG Lingquan, HUANG Tao. Clinical diagnosis, treatment and analysis of 71 cases of chromophobe renal cell carcinoma in a single center[J]. Chinese Journal of General Practice, 2023, 21(9): 1453-1456. doi: 10.16766/j.cnki.issn.1674-4152.003144

Clinical diagnosis, treatment and analysis of 71 cases of chromophobe renal cell carcinoma in a single center

doi: 10.16766/j.cnki.issn.1674-4152.003144
Funds:

 2022AH051256

  • Received Date: 2023-06-04
    Available Online: 2023-10-19
  •   Objective  To investigate the clinical features, pathological features, surgical efficacy and prognosis of chromophobe renal cell carcinoma (chRCC), and to improve the level of diagnosis and treatment of this disease.  Methods  Clinical and follow-up data of 71 patients with chRCC from the First Affiliated Hospital of University of Science and Technology of China from June 2015 to March 2023 were retrospectively analyzed. Clinical experience was summarized. Meanwhile, the perioperative indexes of the partial nephrectomy (PN) group and the radical nephrectomy (RN) group were compared.  Results  There were 26 cases of PN and 45 cases of RN in 71 patients with chRCC. There were 24 cases of T1a, 31 cases of T1b, 12 cases of T2a, and 4 cases of T2b. CT mainly showed isodense or slightly low-density solid space occupying in the kidney, light and moderate enhancement in the arterial phase, and the enhancement degree was lower than the renal parenchyma, showing a slowly increasing state, and the enhancement degree in the venous phase and the delayed phase slowly decreased. Among 65 cases, 61 cases were positive for CD117 staining, and 1 case was weakly positive. Among 69 cases, 62 cases were positive for CK7 staining, and 1 case was weakly positive. Vimentin staining was negative in 54 of 60 cases. Among 44 cases, 33 were positive for colloidal iron staining and 8 were weakly positive. Seventy cases of Ki-67 were all positive, with a median Ki-67 value of 4.5%. There were no statistically significant differences in age, preoperative creatinine clearance (Ccr), intraoperative blood loss, postoperative hemoglobin decline, postoperative albumin decline, drainage indent time and postoperative hospital stay between PN and RN groups (all P > 0.05). The postoperative Ccr in PN group was significantly better than that in RN group, and the maximum tumor diameter and T stage in PN group were lower than those in RN group (all P < 0.05). Sixty-eight patients were followed up successfully, and all of them were tumor free until the end of follow-up.  Conclusion  chRCC is a rare, low malignant and low invasive subtype of renal cell carcinoma with good prognosis. It has unique CT imaging findings and can be confirmed by routine pathology and immunohistochemistry. PN is superior to RN in renal function protection, and PN is a safe and effective surgical method for treating chRCC at T1 stage.

     

  • loading
  • [1]
    SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
    [2]
    GARJE R, ELHAG D, YASIN H A, et al. Comprehensive review of chromophobe renal cell carcinoma[J]. Crit Rev Oncol Hematol, 2021, 160: 103287. DOI: 10.1016/j.critrevonc.2021.103287.
    [3]
    WARREN A Y, HARRISON D. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies[J]. World J Urol, 2018, 36(12): 1913-1926. doi: 10.1007/s00345-018-2447-8
    [4]
    THOENES W, STÖRKEL S, RUMPELT H J. Human chromophobe cell renal carcinoma[J]. Virchows Arch B Cell Pathol Incl Mol Pathol, 1985, 48(3): 207-217.
    [5]
    王旭, 宋歌, 王宗平, 等. 早期富血供超小肾癌与肾乏脂肪血管平滑肌脂肪瘤的CT鉴别诊断[J]. 中华全科医学, 2020, 18(6): 989-993, 1017. doi: 10.16766/j.cnki.issn.1674-4152.001410

    WANG X, SONG G, WANG Z P, et al. CT differential diagnosis of early ultra-small renal carcinoma with rich blood supply and adipose-deficient renal angiomyolipoma[J]. Chinese Journal of General Practice, 2020, 18(6): 989-993, 1017. doi: 10.16766/j.cnki.issn.1674-4152.001410
    [6]
    于永梅, 王敏, 翟蕊, 等. CT对肾细胞癌亚型的诊断及鉴别诊断[J]. 实用放射学杂志, 2022, 38(10): 1659-1663. doi: 10.3969/j.issn.1002-1671.2022.10.023

    YU Y M, WANG M, ZHAI R, et al. CT diagnosis and differential diagnosis of renal cell carcinoma subtypes[J]. Journal of Practical Radiology, 2022, 38(10): 1659-1663. doi: 10.3969/j.issn.1002-1671.2022.10.023
    [7]
    REN W, XUE B, QU J, et al. Localized chromophobe renal cell carcinoma: preoperative imaging judgment and laparoscopic simple enucleation for treatment[J]. Int Braz J Uro, 2018(5): 922-932.
    [8]
    MARKO J, CRAIG R, NGUYEN A, et al. Chromophobe renal cell carcinoma with radiologic-pathologic correlation[J]. Radiographics, 2021, 41(5): 1408-1419. doi: 10.1148/rg.2021200206
    [9]
    张巍, 李真真, 陈洁, 等. 肾嗜酸细胞瘤的临床病理特征[J]. 中国组织化学与细胞化学杂志, 2022, 31(1): 52-57, 67. https://www.cnki.com.cn/Article/CJFDTOTAL-GGZZ202201007.htm

    ZHANG W, LI Z Z, CHEN J, et al. Clinicopathological features of renal eosinophilic tumours[J]. Chinese Journal of Histochemistry and Cytochemistry, 2022, 31(1): 52-57, 67. https://www.cnki.com.cn/Article/CJFDTOTAL-GGZZ202201007.htm
    [10]
    ALAGHEHBANDAN R, PRZYBYCIN C G, VERKARRE V, et al. Chromophobe renal cell carcinoma: novel molecular insights and clinicopathologic updates[J]. Asian J Urol, 2022, 9(1): 1-11. doi: 10.1016/j.ajur.2021.11.010
    [11]
    白红松, 王栋, 温力, 等. 126例肾嫌色细胞癌的诊治分析[J]. 中国医学科学院学报, 2021, 43(2): 247-252. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYKX202102015.htm

    BAI H S, WANG D, WEN L, et al. Diagnosis and treatment of 126 cases of chromophobe renal cell carcinoma[J]. Journal of Chinese Academy of Medical Sciences, 2021, 43(2): 247-252. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYKX202102015.htm
    [12]
    YANG J, GONG C, ZHAO J, et al. Effects of BAP1, Ki-67 index, and Id-1 in patients with clear cell renal carcinoma and their correlation with clinical features and prognosis[J]. Transl Androl Urol, 2020, 9(5): 2242-2250. doi: 10.21037/tau-20-1258
    [13]
    SONG J, YU Z, DONG B, et al. Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma[J]. World J Surg Oncol, 2021, 19(1): 156. doi: 10.1186/s12957-021-02268-5
    [14]
    CASUSCELLI J, BECERRA M F, SEIER K, et al. Chromophobe renal cell carcinoma: results from a large single-institution series[J]. Clin Genitourin Cancer, 2019, 17(5): 373-379. e4. doi: 10.1016/j.clgc.2019.06.011
    [15]
    GED Y, CHEN Y B, KNEZEVIC A, et al. Metastatic chromophobe renal cell carcinoma: presence or absence of sarcomatoid differentiation determines clinical course and treatment outcomes[J]. Clin Genitourin Cancer, 2019, 17(3): e678-e688. doi: 10.1016/j.clgc.2019.03.018
    [16]
    NEVES J B, VANACLOCHA SAIZ L, ABU-GHANEM Y, et al. Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma[J]. World J Urol, 2021, 39(10): 3823-3831. doi: 10.1007/s00345-021-03683-9
    [17]
    PECORARO A, PALUMBO C, KNIPPER S, et al. Synchronous metastasis rates in T1 renal cell carcinoma: a surveillance, epidemiology, and end results database-based study[J]. Eur Urol Focus, 2021, 7(4): 818-826. doi: 10.1016/j.euf.2020.02.011
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(1)

    Article Metrics

    Article views (410) PDF downloads(32) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return